Zwenneke Flach

1.5k total citations
6 papers, 89 citations indexed

About

Zwenneke Flach is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Zwenneke Flach has authored 6 papers receiving a total of 89 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in Zwenneke Flach's work include Radiomics and Machine Learning in Medical Imaging (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Glioma Diagnosis and Treatment (3 papers). Zwenneke Flach is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Glioma Diagnosis and Treatment (3 papers). Zwenneke Flach collaborates with scholars based in Netherlands. Zwenneke Flach's co-authors include Aad van der Lugt, Miriam Sturkenboom, Rashindra Manniesing, Wiro J. Niessen, Fop van Kooten, Roelof Risselada, Monique C.J. Hanse, Marion Smits, Walter Taal and Laurens V. Beerepoot and has published in prestigious journals such as Neuro-Oncology, European Journal of Radiology and EuroIntervention.

In The Last Decade

Zwenneke Flach

6 papers receiving 88 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zwenneke Flach Netherlands 4 45 39 37 24 19 6 89
Ahmed E. Fetit United Kingdom 7 21 0.5× 122 3.1× 51 1.4× 7 0.3× 14 0.7× 12 169
Rania Abdelkhaleq United States 8 71 1.6× 40 1.0× 33 0.9× 63 2.6× 7 0.4× 26 211
Kavi Fatania United Kingdom 7 33 0.7× 29 0.7× 14 0.4× 15 0.6× 2 0.1× 15 100
L. Cerdá Alberich Spain 6 11 0.2× 46 1.2× 13 0.4× 27 1.1× 4 0.2× 16 98
Andra Curcean United Kingdom 7 32 0.7× 57 1.5× 6 0.2× 9 0.4× 4 0.2× 14 126
Sergio Salazar‐Marioni United States 7 37 0.8× 25 0.6× 4 0.1× 51 2.1× 6 0.3× 26 184
Tanja Janjic Austria 6 34 0.8× 29 0.7× 12 0.3× 3 0.1× 5 0.3× 9 87
Nicole Porz Switzerland 4 15 0.3× 117 3.0× 84 2.3× 4 0.2× 34 1.8× 8 158
Paweł Krukowski Germany 5 47 1.0× 33 0.8× 36 1.0× 22 0.9× 10 106
Marcus Ohlsson Sweden 7 14 0.3× 9 0.2× 20 0.5× 14 0.6× 12 121

Countries citing papers authored by Zwenneke Flach

Since Specialization
Citations

This map shows the geographic impact of Zwenneke Flach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zwenneke Flach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zwenneke Flach more than expected).

Fields of papers citing papers by Zwenneke Flach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zwenneke Flach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zwenneke Flach. The network helps show where Zwenneke Flach may publish in the future.

Co-authorship network of co-authors of Zwenneke Flach

This figure shows the co-authorship network connecting the top 25 collaborators of Zwenneke Flach. A scholar is included among the top collaborators of Zwenneke Flach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zwenneke Flach. Zwenneke Flach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Gahrmann, Renske, Marion Smits, René M. Vernhout, et al.. (2022). The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology Advances. 4(1). vdac032–vdac032. 3 indexed citations
2.
Gahrmann, Renske, Martin J. van den Bent, Bronno van der Holt, et al.. (2017). Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial. Neuro-Oncology. 19(6). 853–861. 37 indexed citations
3.
Gahrmann, Renske, Martin J. van den Bent, Bronno van der Holt, et al.. (2016). NIMG-13. RADIOLOGICAL RESPONSE ASSESSMENT IN THE ERA OF BEVACIZUMAB: RANO OR VOLUMETRY? A REPORT FROM THE BELOB TRIAL. Neuro-Oncology. 18(suppl_6). vi126–vi126. 1 indexed citations
4.
Manniesing, Rashindra, Zwenneke Flach, Roelof Risselada, et al.. (2010). Intracranial aneurysm segmentation in 3D CT angiography: Method and quantitative validation with and without prior noise filtering. European Journal of Radiology. 79(2). 299–304. 41 indexed citations
5.
Manniesing, Rashindra, Zwenneke Flach, Roelof Risselada, et al.. (2010). Intracranial aneurysm segmentation in 3D CT angiography: method and quantitative validation. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7623. 76233M–76233M. 1 indexed citations
6.
Flach, Zwenneke, Mohamed Ouhlous, Johanna M. Hendriks, et al.. (2007). Diffusion-weighted imaging to compare different cerebral protection devices in carotid artery stenting. EuroIntervention. 3(2). 243–248. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026